(c) The authors
A great deal of experience has now accumulated on the clinical efficacy of vaccines against Covid-19 but the important issue of the optimum length of time between first and booster vaccination in older adults was not immediately clear. This paper surveyed spike-specific antibody and T cell responses in people over 80 years of age after the second dose of either Pfizer/BioNTech BNT162b2 mRNA or AstraZeneca/Oxford ChAdOx1 adenovirus vaccine administered after an ‘extended interval’ of 8-12 weeks rather than the 4-week schedule originally stipulated. Importantly, results showed that both vaccines delivered in this manner elicited strong humoral immunity in older adults, but with antibody responses following BNT162b2 higher than after ChAdOx1, but T cell responses higher after the adenovirus-based vaccine.
Due to the cancellation of the meeting “Immunity, Metabolism and Aging”, scheduled to take place in Modena (Italy), September 24-25 2020, for the difficult circumstances created by the global COVID-19 pandemic, we have suggested a "Symposium-in-Writing" whereby the speakers that have already accepted to give a talk in Modena will submit a paper to this special issue of the journal Immunity & Ageing. Daniela Frasca and Andrea Cossarizza
‘Immunosenescence’ describes the multifactorial changes in the immune system with advanced age. To increase our understanding of the conditions of immune function in aging, the focus of this special issue is to document biomarkers of age-related immune conditions. We seek articles which highlight validated biomarkers or approaches to quantify immune aging, clarify heterogeneity among changes that accrue in aging, identify mechanisms underlying the altered state, or highlight where interventions may serve to improve health. Articles may be commentaries or original research. Articles especially welcomed will address conceptual topics, detectable biomarkers, or clinical implications.
This topical collection will explore how complex neuroimmune interactions promote healthy and pathological ageing. We seek reviews, viewpoints, commentaries, or original research articles exploring the role of stress, mood disorders, and sensory systems during normal and premature immunosenescence. Over the last few decades, increasing evidence is implicating a role for the immune system in brain physiology and behaviour. Therefore, we also welcome articles discussing the role of immune cells and cytokines for the ageing brain, as well as the role of inflammation in neuromuscular disorders associated with senescence. In addition, we seek articles exploring the role of immunosenescence in age-related pathologies of the nervous system, including neurodegenerative and autoimmune disorders (e.g., AD, PD and MS), as well as the role of vascular disease in neurodegeneration. In the context of the COVID-19 pandemic, we also seek articles discussing post-infectious degeneration in older adults.
Immunity & Ageing, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
Thematic series
Towards Biomarkers of Human Immunosenescense
Ruth Montgomery and Alan Cohen
Thematic series
Immunity, Metabolism and Aging
Daniela Frasca and Andrea Cossarizza
Thematic series
Nutrigerontology: a key for achieving successful ageing and longevity
Collection published: April/ May 2016
Cross journal collection
Day of Immunology 2015
Collection published: 28 April 2015
Thematic series
Positive biology: the centenarian lesson
Immunity & Ageing
Collection published: 23 April 2012
The increasing realization that immune ageing and organismal ageing are intimately inter-related puts the immune system at centre-stage in our efforts to understand and manipulate the ageing process.
Immunity & Ageing provides a specific conduit for dissemination of new knowledge in this increasingly important arena. Published since 2004, the journal is a specialist open access journal dedicated to promulgating information on the impact of ageing on immune systems, the influence of aged immune systems on organismal well-being and longevity, age-associated diseases which have at least partly an immune etiology, and potential immune interventions to increase health span.
Immunity & Ageing welcomes submissions dealing with any aspect of ageing in human and model organisms that relates to immune function. Papers dealing with any aspect of ageing that does not include a substantial immunological element will not be considered.
View the most shared articles across the past month
Graham Pawelec is Professor of Experimental Immunology at the University of Tübingen, Germany, where he led the Tübingen Ageing and Tumour Immunology (TATI) group from 1999 to 2017. He is currently affiliated with the Health Sciences North Research Institute of Canada, Sudbury, ON, and is a Visiting Professor at Nottingham Trent University, King´s College London, and Manchester University, UK. His research interests remain centered on immunogerontology in the context of cancer immunology and immunotherapy, and vaccination.
Nan-ping Weng is tenured senior investigator, Chief of Lymphocyte Differentiation Section, Laboratory of Molecular Biology and Immunology at the National Insitute on Aging (NIA), NIH. He joined the Laboratory of Immunology at the NIA as a tenure-track investigator in 1997 and has been tenured senior investigator since 2006. His laboratory focuses on the understanding of molecular and cellular mechanisms of T cell differentiation and age-associated decline of T cell functions.
Professor Calogero Caruso MD Professor of General Pathology and Director of Palermo University Medical School “Ippocrate”
Whether your interests are immunological aspects of ageing, age-related diseases and longevity, this journal can serve as an appropriate venue.
Speed
61 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
119 days from submission to acceptance
16 days from acceptance to publication
Citation Impact
6.400 - 2-year Impact Factor
5.366 - 5-year Impact Factor
1.307 - Source Normalized Impact per Paper (SNIP)
1.409 - SCImago Journal Rank (SJR)
Usage
212,224 Downloads
343 Altmetric mentions